ResearchMoz

PDS Biotechnology Corporation - Product Pipeline Review - 2014

Global Markets Direct
Published Date » 2014-07-10
No. Of Pages » 22
PDS Biotechnology Corporation - Product Pipeline Review - 2014  Summary  Global Markets Directs, PDS Biotechnology Corporation - Product Pipeline Review - 2014, provides an overview of the PDS Biotechnology Corporations pharmaceutical research and development focus.  This report provides comprehensive information on the current therapeutic developmental pipeline of PDS Biotechnology Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.  Global Markets Directs report features investigational drugs from across globe covering...
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
PDS Biotechnology Corporation Snapshot 4
PDS Biotechnology Corporation Overview 4
Key Information 4
Key Facts 4
PDS Biotechnology Corporation - Research and Development Overview 5
Key Therapeutic Areas 5
PDS Biotechnology Corporation - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
PDS Biotechnology Corporation - Pipeline Products Glance 11
PDS Biotechnology Corporation - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
PDS Biotechnology Corporation - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
PDS Biotechnology Corporation - Drug Profiles 13
PDS-0101 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Immunotherapies for Non-Viral Cancers 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PDS-0102 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PDS Biotechnology Corporation - Pipeline Analysis 17
PDS Biotechnology Corporation - Pipeline Products by Route of Administration 17
PDS Biotechnology Corporation - Pipeline Products by Molecule Type 18
PDS Biotechnology Corporation - Recent Pipeline Updates 19
PDS Biotechnology Corporation - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 22
Disclaimer 22

List of Tables
PDS Biotechnology Corporation, Key Information 4
PDS Biotechnology Corporation, Key Facts 4
PDS Biotechnology Corporation - Pipeline by Indication, 2014 6
PDS Biotechnology Corporation - Pipeline by Stage of Development, 2014 7
PDS Biotechnology Corporation - Monotherapy Products in Pipeline, 2014 8
PDS Biotechnology Corporation - Partnered Products in Pipeline, 2014 9
PDS Biotechnology Corporation - Partnered Products/ Combination Treatment Modalities, 2014 10
PDS Biotechnology Corporation - Phase I, 2014 11
PDS Biotechnology Corporation - Preclinical, 2014 12
PDS Biotechnology Corporation - Pipeline by Route of Administration, 2014 17
PDS Biotechnology Corporation - Pipeline by Molecule Type, 2014 18
PDS Biotechnology Corporation - Recent Pipeline Updates, 2014 19

List of Figures
PDS Biotechnology Corporation - Pipeline by Top 10 Indication, 2014 6
PDS Biotechnology Corporation - Pipeline by Stage of Development, 2014 7
PDS Biotechnology Corporation - Monotherapy Products in Pipeline, 2014 8
PDS Biotechnology Corporation - Pipeline by Top 10 Route of Administration, 2014 17
PDS Biotechnology Corporation - Pipeline by Top 10 Molecule Type, 2014 18

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Greece: generating sets market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the generating sets market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the generating sets market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview...
Systemic Lupus Erythematosus Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. Common symptoms include fever, fatigue, skin rashes, malaise, joint pain, and temporary loss of cognitive ability. The disease is more common in women and usually affects individuals in the age group of 25 to 45....
Factor Assays Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Factor assays are mainly undertaken during prolongation of the Activated Partial Thromboplastin Time (APTT) and Partial Thromboplastin Time (PTT) resulting in the deficiency of one or more clotting proteins. Overall a basic general principle is followed by all functional clotting factor assays that involves specific plotting/clotting time from either PTT or APTT depending on which factor it’s being assayed against sample dilution. A quantitative assay of an individual clotting factor is essential to identify inherited deficiency and to monitor replacement therapy and sometimes helps...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

DOD Spending Low, Corps Look for More Work in Alaska
Nov 24, 2014  
Military construction across Alaska continues to decline. Government contractors expect to keep busy for the time being with work delegated by other federal agencies. The United States Army Corps of Engineers expects to have more than US$410 million worth of work available on at least 400 projects in the 2015 fiscal year. Chris Tew, the Alaska Contracting Division chief said that is...
Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Los Angeles Auto Show Kicks Off
Nov 20, 2014  
The Los Angeles Auto Show kicked off on Wednesday with a rather upbeat mood. Motoring machines, industry metrics, and hybrid models – the show has lived up to its reputation once more. The Los Angeles Auto Show has begun touring North America from the Los Angeles Convention Center, and the commencement has already had an impact on the market. Gasoline prices dropped under US$3...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...